Each filer's latest filing for 03969F109 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Gilead Sciences, Inc. 13D/A | 24.7% |
8/7/2026
Event 8/5/2026
|
||
| BlackRock, Inc. 13G/A | 10.4% |
1/8/2026
Event 12/31/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
Point72 Asset Management, L.P.
13G/A
|
4.1% |
11/14/2025
Event 9/30/2025
|
||
| Point72 Asset Management, L.P. | 4.1% | |||
| Point72 Capital Advisors, Inc. | 4.1% | |||
| Steven A. Cohen | 4.1% | |||
| Vanguard Group Inc 13G/A | 0% |
3/26/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 246 | 125 M | $3.23B |
| 2026 Q2 | 233 | 123 M | $3.78B |
| 2026 Q1 | 212 | 119 M | $2.57B |
| 2025 Q4 | 212 | 121 M | $2.89B |
| 2025 Q3 | 191 | 101 M | $1.37B |
| 2025 Q2 | 188 | 99.7 M | $812M |
| 2025 Q1 | 189 | 97.2 M | $763M |
| 2024 Q4 | 187 | 83.9 M | $1.25B |
| 2024 Q3 | 189 | 53.3 M | $815M |
| 2024 Q2 | 196 | 52.0 M | $791M |
| 2024 Q1 | 175 | 52.9 M | $998M |
| 2023 Q4 | 189 | 52.8 M | $1.01B |
| 2023 Q3 | 189 | 52.8 M | $948M |
| 2023 Q2 | 184 | 54.7 M | $1.11B |
| 2023 Q1 | 183 | 55.5 M | $1.01B |
| 2022 Q4 | 205 | 53.8 M | $1.11B |
| 2022 Q3 | 185 | 52.5 M | $1.37B |
| 2022 Q2 | 179 | 52.4 M | $1.33B |
| 2022 Q1 | 161 | 50.6 M | $1.60B |
| 2021 Q4 | 148 | 50.8 M | $2.06B |
| 2021 Q3 | 133 | 48.3 M | $1.68B |
| 2021 Q2 | 135 | 45.2 M | $1.24B |
| 2021 Q1 | 152 | 44.7 M | $1.25B |
| 2020 Q4 | 151 | 44.6 M | $1.16B |
| 2020 Q3 | 130 | 44.4 M | $761M |
| 2020 Q2 | 142 | 41.8 M | $1.03B |
| 2020 Q1 | 93 | 27.0 M | $375M |
| 2019 Q4 | 76 | 27.1 M | $274M |
| 2019 Q3 | 76 | 25.8 M | $235M |
| 2019 Q2 | 79 | 26.4 M | $210M |
| 2019 Q1 | 65 | 25.8 M | $322M |
| 2018 Q4 | 68 | 26.9 M | $290M |
| 2018 Q3 | 59 | 22.5 M | $313M |
| 2018 Q2 | 64 | 22.4 M | $274M |
| 2018 Q1 | 57 | 19.9 M | $293M |